Please login to the form below

Not currently logged in
Email:
Password:

Portland Health appoints new associate director Matt Worrall

He joins as the London health comms agency celebrates its first anniversary
Portland, Matt Worrall

Matt Worrall will tomorrow join Portland Health as an associate director, moving to the agency from Hanover, where he worked with a range of pharma and NHS clients.

Before joining Hanover, Worrall was head of communications at the Royal College of Surgeons and he has also worked for the Association of the British Pharmaceutical Industry (ABPI), focusing on media campaigns, stakeholder relations and crisis communications.

At London-based Portland Worrall will help manage the health team and will line manage three posts.

Louise Fish, head of health, told PMLiVE: “We are delighted that Matt is bringing his expertise to the team, and with more sector knowledge and capacity, I am sure that Portland Health will continue to flourish and deliver positive results for our clients.

“Portland Health continues to go from strength to strength.  It's an exciting time for us with our integrated public relations and public affairs offering making the most of the team's extensive experience.”

Portland has also recently hired account executives Rebecca Rollinson and Alice Beard and a new account manager will join mid-April, Fish told PMLiVE. 

The agency also marked its first anniversary by bringing its health client list to 12 after recently winning the ABPI Pharmaceutical Diabetes Initiative, for which it will deliver a strategic public affairs campaign designed to drive improved diagnosis and management of people with diabetes.

1st April 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...